Measurement of Hemoglobin Adducts in Female Mice Inhaled with 1,3-butadiene by Using GC/MS

  • Lee, Jin-Heon (Dept. of Environmental Education, Kongju National University) ;
  • Shin, Ho-Sang (Dept. of Environmental Education, Kongju National University)
  • 발행 : 2004.11.01

초록

1,3-butadiene(DB) is a well-established rodent carcinogen, and a probable carcinogen to humans. This study was investigated the formation of hemoglobin adduct in ICR female mice inhaled with BD for 3 weeks (5 hr/day, 5 days/week). Body weights of mice were significantly low from onward day 4 or 9 of exposure comparing the control. Hemoglobin adducts formed by DB exposure were (N-2-hydroxy-3-butenyl) valine (HB Val adduct) and (N-2,3,4-trihydroxy-butyl)valine(THB Val adduct). The levels of HB Val adducts were 1.8, 3.7 and 6.2 pmol/mg globin for the 500 ppm BD inhalation group, and 5.7, 7.4 and 16.0 pmol/mg globin for the 1000 ppm BD inhalation group, when observed on the $1^{st},\;2^{nd},\;and\;3^{rd}$ week after inhalation exposure, respectively. The levels of THBVal adducts were 32.0, 42.0 and 55.0 pmol/mg globin for the 500 ppm DB inhalation group, and 67.8, 72.7 and 83.5 pmol/mg globin for the 1000 ppm BD inhalation group, when observed on the $1^{st},\;2^{nd},\;and\;3^{rd}$ week after inhalation exposure, respectively. Ratios of THBVal and HBVal adducts were higher at earlier exposure period and lower concentration. Ratios on the $1^{st},\;2^{nd},\;and\;3^{rd}$ week were 17.8, 11.4 and 8.87 for the 500 ppm BD inhalation group, and 11.9, 9.8 and 5.2 for the 1000 ppm BD inhalation group, respectively. In conclusion, THB Val and HB Val adducts were the important hemoglobin adducts in ICR female mice inhaled with BD, and the latter was more appropriate biomarker than the other for biological monitoring of BD exposure.

키워드

참고문헌

  1. ACGIH : Threshold limit values and biological exposure indices. American Conference of Governmental Industrial Hygienists, Cincinnati, OH, USA, 2002
  2. Albertini, R.J., Sram, R.J., Vacek, P.M., Lynch, J., Wright, M., Nicklas, J.A., Boogaard, P.B., Henderson, R.F., Swenberg, J.A., Tates, A.D. and Ward Jr, J.B.: Biomarkers for assessing occupational exposures to 1,3-butadiene, Chemico-Biological Interactions, 135-136, 429-453, 2001 https://doi.org/10.1016/S0009-2797(01)00181-8
  3. Albrecht, O.E., Filser, J.E. and Neumann, H.G. : Biological monitoring of 1,3-butadiene: species differences in hemoglobin binding in rats and mouse, in Butadiene and styrene: Assessment of health hazards, IARC Scientific Publications, Lyon, 135-142, 1993
  4. Bernard, A and Lauwerys, R. : Present status and trends in biological monitoring of exposure to industrial chemicals. J. Occup. Med., 28, 559, 1986 https://doi.org/10.1097/00043764-198608000-00006
  5. Committee of Biological Markers of the National Research Council : Biological markers in environmental health research. Environ. Health Perspect., 74, 3-9, 1987 https://doi.org/10.2307/3430428
  6. Department of Health and Human Services (US) : 1,3-butadiene. in the ninth report on carcinogens. National Toxicology Program, Research Triangle Park, NC, USA, 2000
  7. Deutsche Forschungsgemeinschaft : List of MAK and BAT values. Commission for the Investigation of Health Hazard of Chemicals Compounds in the Work Area, Report N.35, Wiley-VCH, Weinheim, DE, 2002
  8. Environmental Protection Agency(US) : Health risk assessment of 1,3-butadiene. EPA/600/P-98/001F. National Office for Environmental Assessment Washington Office, Office of Research and Development, US EPA, Washington, DC, USA, 2002
  9. Fustinoni, S., Perbellini, L, Soleo, L, Manno, M. and Foa, V. : Biological monitoring in occupational exposure to low levels of 1,3-butadiene. Toxicology Letters, 149, 353-360, 2004 https://doi.org/10.1016/j.toxlet.2003.12.046
  10. Henderson, R.E, Bechtold, w.E., Sabourin, P.J. Maples, K.R. and Dahl, A.R. : Species differences in the metabolism of 1,3-butadiene in vivo. In: M. Sorsa, K. Poltonen, H. Vainio and K. Hemminki (Eds), Butadiene and Styrene: Assessment of Health Hazards. IARC Scientific Publications, 127, 57-64, 1993
  11. Huff, J.E., Melnick, R.L., Solleveld, H.A., Haseman, J.K., Powers, M. and Miller, R.A. : Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure, Science (Washington, D.C.), 227, 548-549, 1985 https://doi.org/10.1126/science.3966163
  12. IARC : 1,3-butadiene, IARC monographs on the evaluation of carcinogenic risks to humans. 71, 109, 1999
  13. Himmelstein, M.W., Acquavella, J.F., Recio, L., Medinsky, M.A and Bond, J.A : Toxicology and epidemiologyof 1,3-butadiene. Crit. Rev. Toxicol. 27, 1-108, 1997 https://doi.org/10.3109/10408449709037482
  14. Lauwerys, R.R. and Hoet, P. : Industrial chemical exposure II Guidelines for biological monitoring, Lewis Publishers (2nd Eds), 1-13, 1993
  15. Lee, J.H. and Shin, H.S. : Determination of hemoglobin adducts formed in rats exposed orally with 3,3II-dichlorobenzidine by GC/MS-SIM. Toxicology and Industrial Health, 18, 191-199, 2002 https://doi.org/10.1191/0748233702th142oa
  16. Melnick, R.L., Huff, J., Chou, J. and Miller, R.A. : Carcinogenicity of 1,3-butadiene in B6C3F1 mice at low exposure concentrations, Cancer Res., 50, 6592-6599, 1990
  17. Osterman-Golkar, M., Moss, O., James, A., Bryant, M.S., Turner, M. and Bond, J.A. : Epoxybutenehemoglobin adducts in rat and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene. Toxicology and Applied Pharmacology, 150, 166-173, 1998 https://doi.org/10.1006/taap.1998.8376
  18. Osterman-Golkar, S., Peltonen, K., Anttinen-Klemetti, T., Hindso Landin, H., Zorcec, V. and Sorsa, M. : Hemoglobin adducts as biomarkers of occupational exposure to 1,3-butadiene. Mutagenesis, 10, 145-149, 1996
  19. Owen, P.E., Glaister, J.R., Gaunt, I.F. and Pullinger, D.H. : Inhalation toxicity studies with 1,3-butadiene. III. Two years toxicity/carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J., 48, 407-413, 1987 https://doi.org/10.1080/15298668791384959
  20. Perez, H.L., Lahdetie, J., Landin, H.H., Kilpelainen, I., Koivisto, P. and Osterman-Golkar, S. : Hemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides. Chem-BioI. Interact., 105, 181-198, 1997 https://doi.org/10.1016/S0009-2797(97)00049-5
  21. Swenberg, J.A, Koc, H., Upton, P.B., Georguieva, N., Ranasinghe, A., Walker, V.E. and Henderson, R. : Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chemico-Biological Interactions, 135-136, 387-403, 2001 https://doi.org/10.1016/S0009-2797(01)00221-6
  22. Swenberg, J.A., Christova Gueorguieva, Upton, N.I., Ranasinghe, P.B., Scheller, A., Wu, N. and Hayes, K.Y. : 1,3-butadiene: cancer mutation and adducts. Part V: Hemoglobin adducts as biomarker of 1,3-butadiene exposure and metabolism. Res. Rep. Health Eff. Inst., 92, 191-210, 2000
  23. Van Putten, L.M. : The life span of red cells in the rats and the mouse as determined by labeling with $DFP^3^2$ in vivo, Blood, 13, 789-794, 1958